Twenty-two Abstracts to be Presented, Including New Data Analyses from the ARISTOTLE Pivotal Phase 3 Study and Real-World Data Analyses
Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the American Heart Association (AHA) Scientific Sessions 2015 | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.